Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 962

1.

Features and Prognostic Significance of Intraductal Carcinoma of the Prostate.

Montironi R, Zhou M, Magi-Galluzzi C, Epstein JI.

Eur Urol Oncol. 2018 May;1(1):21-28. doi: 10.1016/j.euo.2018.03.013. Epub 2018 May 15. Review.

PMID:
31100224
2.

Intraductal Carcinoma of the Prostate in the Absence of High Grade Invasive Carcinoma Represents a Molecularly Distinct Type of in situ Carcinoma Enriched with Oncogenic Driver Mutations.

Khani F, Wobker SE, Hicks JL, Robinson BD, Barbieri CE, De Marzo AM, Epstein JI, Pritchard CC, Lotan TL.

J Pathol. 2019 Apr 16. doi: 10.1002/path.5283. [Epub ahead of print]

PMID:
30993692
3.

DNA damage repair alterations are frequent in prostatic adenocarcinomas with focal pleomorphic giant-cell features.

Lotan TL, Kaur HB, Alharbi AM, Pritchard CC, Epstein JI.

Histopathology. 2019 May;74(6):836-843. doi: 10.1111/his.13806. Epub 2019 Apr 1.

PMID:
30636012
4.

Defining clinically significant prostate cancer on the basis of pathological findings.

Matoso A, Epstein JI.

Histopathology. 2019 Jan;74(1):135-145. doi: 10.1111/his.13712. Review.

PMID:
30565298
5.

Neuroglial Differentiation and Neoplasms in Testicular Germ Cell Tumors Lack Immunohistochemical Evidence of Alterations Characteristic of Their CNS Counterparts: A Study of 13 Cases.

Matoso A, Idrees MT, Rodriguez FJ, Ibrahim J, Perrino CM, Ulbright TM, Epstein JI.

Am J Surg Pathol. 2019 Mar;43(3):422-431. doi: 10.1097/PAS.0000000000001206.

PMID:
30557172
6.

Mimickers of urothelial neoplasia.

Kryvenko ON, Epstein JI.

Ann Diagn Pathol. 2019 Feb;38:11-19. doi: 10.1016/j.anndiagpath.2018.09.012. Epub 2018 Sep 26. Review.

PMID:
30380401
7.

VSTM2A Overexpression Is a Sensitive and Specific Biomarker for Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the Kidney.

Wang L, Zhang Y, Chen YB, Skala SL, Al-Ahmadie HA, Wang X, Cao X, Veeneman BA, Chen J, CieĊ›lik M, Qiao Y, Su F, Vats P, Siddiqui J, Xiao H, Sadimin ET, Epstein JI, Zhou M, Sangoi AR, Trpkov K, Osunkoya AO, Giannico GA, McKenney JK, Argani P, Tickoo SK, Reuter VE, Chinnaiyan AM, Dhanasekaran SM, Mehra R.

Am J Surg Pathol. 2018 Dec;42(12):1571-1584. doi: 10.1097/PAS.0000000000001150.

PMID:
30285995
8.

Granular Cell Tumor of the Bladder: A Report of Six Cases.

Sun Y, Reuter VE, Magi-Galluzzi C, Sankin A, Epstein JI.

Urology. 2018 Nov;121:203.e1-203.e5. doi: 10.1016/j.urology.2018.08.018. Epub 2018 Aug 29.

PMID:
30170086
9.

PIN-like (Ductal) Adenocarcinoma of the Prostate.

Paulk A, Giannico G, Epstein JI.

Am J Surg Pathol. 2018 Dec;42(12):1693-1700. doi: 10.1097/PAS.0000000000001139.

PMID:
30138215
10.

Older Age Predicts Biopsy and Radical Prostatectomy Grade Reclassification to Aggressive Prostate Cancer in Men on Active Surveillance.

Druskin SC, Mamawala M, Tosoian JJ, Epstein JI, Pavlovich CP, Carter HB, Trock BJ.

J Urol. 2019 Jan;201(1):98-104. doi: 10.1016/j.juro.2018.08.023.

PMID:
30114397
11.

How Are Gleason Scores Categorized in the Current Literature: An Analysis and Comparison of Articles Published in 2016-2017.

Zhou AG, Salles DC, Samarska IV, Epstein JI.

Eur Urol. 2019 Jan;75(1):25-31. doi: 10.1016/j.eururo.2018.07.021. Epub 2018 Jul 26.

PMID:
30057131
12.

Acquired Cystic Disease-associated Renal Cell Carcinoma (ACKD-RCC)-like Cysts.

Sun Y, Argani P, Tickoo SK, Epstein JI.

Am J Surg Pathol. 2018 Oct;42(10):1396-1401. doi: 10.1097/PAS.0000000000001124.

PMID:
30001236
13.

Eosinophilic Solid and Cystic (ESC) Renal Cell Carcinomas Harbor TSC Mutations: Molecular Analysis Supports an Expanding Clinicopathologic Spectrum.

Palsgrove DN, Li Y, Pratilas CA, Lin MT, Pallavajjalla A, Gocke C, De Marzo AM, Matoso A, Netto GJ, Epstein JI, Argani P.

Am J Surg Pathol. 2018 Sep;42(9):1166-1181. doi: 10.1097/PAS.0000000000001111.

PMID:
29975249
14.

Prostatic Adenocarcinoma With Focal Pleomorphic Giant Cell Features: A Series of 30 Cases.

Alharbi AM, De Marzo AM, Hicks JL, Lotan TL, Epstein JI.

Am J Surg Pathol. 2018 Oct;42(10):1286-1296. doi: 10.1097/PAS.0000000000001112.

PMID:
29944471
15.

Skene's Glands Adenocarcinoma: A Series of 4 Cases.

Tregnago AC, Epstein JI.

Am J Surg Pathol. 2018 Nov;42(11):1513-1521. doi: 10.1097/PAS.0000000000001108.

PMID:
29901570
16.

Challenges in Pathologic Staging of Renal Cell Carcinoma: A Study of Interobserver Variability Among Urologic Pathologists.

Williamson SR, Rao P, Hes O, Epstein JI, Smith SC, Picken MM, Zhou M, Tretiakova MS, Tickoo SK, Chen YB, Reuter VE, Fleming S, Maclean FM, Gupta NS, Kuroda N, Delahunt B, Mehra R, Przybycin CG, Cheng L, Eble JN, Grignon DJ, Moch H, Lopez JI, Kunju LP, Tamboli P, Srigley JR, Amin MB, Martignoni G, Hirsch MS, Bonsib SM, Trpkov K.

Am J Surg Pathol. 2018 Sep;42(9):1253-1261. doi: 10.1097/PAS.0000000000001087.

PMID:
29878933
17.

Stratifying Risk for Men With Low-Volume Intermediate-Risk Prostate Cancer-Reply.

Patel HD, Tosoian JJ, Carter HB, Epstein JI.

JAMA Oncol. 2018 Aug 1;4(8):1133-1134. doi: 10.1001/jamaoncol.2018.0754. No abstract available.

PMID:
29852039
18.

The Clinical Significance of a Small Component of Choriocarcinoma in Testicular Mixed Germ Cell Tumor (MGCT).

Hassan O, Epstein JI.

Am J Surg Pathol. 2018 Aug;42(8):1113-1120. doi: 10.1097/PAS.0000000000001088.

PMID:
29794869
19.

ETS2 is a prostate basal cell marker and is highly expressed in prostate cancers aberrantly expressing p63.

Torres A, Alshalalfa M, Davicioni E, Gupta A, Yegnasubramanian S, Wheelan SJ, Epstein JI, De Marzo AM, Lotan TL.

Prostate. 2018 Sep;78(12):896-904. doi: 10.1002/pros.23646. Epub 2018 May 15.

PMID:
29761525
20.

Urothelial Carcinoma In Situ of the Bladder With Glandular Differentiation: Report of 92 Cases.

Yang Z, Epstein JI.

Am J Surg Pathol. 2018 Jul;42(7):971-976. doi: 10.1097/PAS.0000000000001073.

PMID:
29683821

Supplemental Content

Loading ...
Support Center